BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7783694)

  • 1. Investigation of single and recurrent stone formers.
    Tiselius HG
    Miner Electrolyte Metab; 1994; 20(6):321-7. PubMed ID: 7783694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
    Worcester EM; Coe FL; Evan AP; Parks JH
    BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP; Penniston KL; Wolf JS; Nakada SY
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content.
    Trinchieri A; Nespoli R; Ostini F; Rovera F; Zanetti G; Pisani E
    J Urol; 1998 Mar; 159(3):654-7. PubMed ID: 9474119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
    Laube N; Schmidt M; Hesse A
    Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis.
    Kourambas J; Aslan P; Teh CL; Mathias BJ; Preminger GM
    J Endourol; 2001 Mar; 15(2):181-6. PubMed ID: 11325090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of renal stone composition with dual-energy computed tomography: an emerging application.
    Eliahou R; Hidas G; Duvdevani M; Sosna J
    Semin Ultrasound CT MR; 2010 Aug; 31(4):315-20. PubMed ID: 20691932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of cystine supersaturation measurements.
    Nakagawa Y; Asplin JR; Goldfarb DS; Parks JH; Coe FL
    J Urol; 2000 Nov; 164(5):1481-5. PubMed ID: 11025687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical investigations in renal stone formers.
    Samuell CT; Kasidas GP
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():112-22. PubMed ID: 7785940
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory methods of predicting primary and recurrent nephrolithiasis].
    Alchinbaev MK; Malik AM; Merkusheva NV; Makhonina IA
    Urologiia; 2000; (5):9-10. PubMed ID: 11392229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of uric acid and cystine stones.
    Hess B
    Urol Res; 1990; 18 Suppl 1():S41-4. PubMed ID: 2291249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.